Pictet Asset Management Sa Chimerix Inc Transaction History

Pictet Asset Management Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.35 $406,469 - $571,978	243,395 Added 32.28%	997,459 $1.86 Million
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $166,447 - $253,809	91,960 Added 13.89%	754,064 $1.46 Million
Q2 2022 Aug 09, 2022	BUY	$1.34 - $5.34 $463,940 - $1.85 Million	346,224 Added 109.61%	662,104 $1.38 Million
Q1 2022 May 13, 2022	BUY	$4.58 - $6.8 $1.45 Million - $2.15 Million	315,880 New	315,880 $1.45 Million

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.